Structure Therapeutics Inc.
GPCR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $58,989 | $54,710 | $42,867 | $33,487 |
| G&A Expenses | $14,798 | $15,741 | $13,444 | $13,574 |
| SG&A Expenses | $14,798 | $15,741 | $13,444 | $13,574 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $73,787 | $70,451 | $56,311 | $47,061 |
| Operating Income | -$73,787 | -$70,451 | -$56,311 | -$47,061 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $8,183 | $8,929 | $9,576 | $10,718 |
| Pre-Tax Income | -$65,604 | -$61,522 | -$46,735 | -$36,343 |
| Tax Expense | $108 | $139 | $98 | $136 |
| Net Income | -$65,712 | -$61,661 | -$46,833 | -$36,479 |
| % Margin | – | – | – | – |
| EPS | -1.11 | -1.08 | -0.81 | -0.63 |
| % Growth | -2.8% | -33.3% | -28.6% | – |
| EPS Diluted | -1.11 | -1.08 | -0.81 | -0.63 |
| Weighted Avg Shares Out | 58,490 | 57,920 | 57,350 | 57,287 |
| Weighted Avg Shares Out Dil | 58,490 | 57,920 | 57,350 | 57,287 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $8,960 | $9,590 | $10,680 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $291 | $291 | $274 | $273 |
| EBITDA | -$65,313 | -$70,160 | -$56,037 | -$46,788 |
| % Margin | – | – | – | – |